Increased prolyl endopeptidase activity in human neoplasia

Regulatory Peptides

Volumn 163, Issue 1-3, 2010, Pages 102-106

  Larrinaga, Gorka ^a   Perez, Itxaro ^a   Blanco, Lorena ^a   López, José I ^b   Andrés, Leire ^b   Etxezarraga, Carmen ^c   Santaolalla, Francisco ^a,d   Zabala, Aitor ^d   Varona, Adolfo ^a   Irazusta, Jon ^a,e  

^a School of Medicine and Dentistry   (Spain)

^b HOSPITAL DE CRUCES   (Spain)

^c HOSPITAL DE BASURTO   (Spain)

^d UNIVERSITY OF THE BASQUE COUNTRY UPV EHU   (Spain)

^e CENTRO DE INVESTIGACIÓN BIOMÉDICA EN RED DE SALUD MENTAL CIBERSAM   (Spain)

Author keywords

Bioactive peptides; Cancer; PEP; Prolyl endopeptidase; Prolyl oligopeptidase; Tumor markers

Indexed keywords

PROLYL ENDOPEPTIDASE;

ADULT; AGED; ARTICLE; CELL MEMBRANE; CLEAR CELL CARCINOMA; COLON; COLORECTAL ADENOMA; CONTROLLED STUDY; CYTOSOL; ENZYME ACTIVITY; FEMALE; FLUOROMETRY; HEAD AND NECK CARCINOMA; HUMAN; HUMAN TISSUE; KIDNEY; KIDNEY CARCINOMA; KIDNEY PELVIS CARCINOMA; LARYNX; MAJOR CLINICAL STUDY; MALE; NEOPLASM; PRIORITY JOURNAL; SQUAMOUS CELL CARCINOMA; TESTIS; THYROID GLAND; UROGENITAL TRACT TUMOR;

ADULT; AGED; AGED, 80 AND OVER; COLORECTAL NEOPLASMS; FEMALE; HUMANS; KIDNEY NEOPLASMS; LARYNGEAL NEOPLASMS; MALE; MIDDLE AGED; MOUTH NEOPLASMS; SERINE ENDOPEPTIDASES; TESTICULAR NEOPLASMS; THYROID NEOPLASMS;

EID: 77953915476     PISSN: 01670115     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.regpep.2010.03.012     Document Type: Article

References (62)

1. Gass J., Khosla C. Prolyl endopeptidases. Cell Mol Life Sci 2007, 64:345-355.
2. Szeltner Z., Polgár L. Structure, function and biological relevance of prolyl oligopeptidase. Curr Protein Pept Sci 2008, 9:96-107.
3. Walter R., Shlank H., Glass J.D., Schwartz I.L., Kerenyi T.D. Leucylglycinamide released from oxytocin by human uterine enzyme. Science 1971, 173:827-829.
4. Goossens F., De Meester I., Vanhoof G., Scharpé S. Distribution of prolyl oligopeptidase in human peripheral tissues and body fluids. Eur J Clin Chem Clin Biochem 1996, 34:17-22.
5. Irazusta J., Larrinaga G., González-Maeso J., Gil J., Meana J.J., Casis L. Distribution of prolyl endopeptidase activities in rat and human brain. Neurochem Int 2002, 40:337-345.
6. García-Hornsman J.A., Männistö P.T., Venäläinen J.I. On the role of prolyl oligopeptidase in health and disease. Neuropeptides 2007, 41:1-24.
7. O'Leary R.M., Gallagher S.P., O'Connor B. Purification and characterization of a novel membrane-bound form of prolyl endopeptidase from bovine brain. Int J Biochem Cell Biol 1996, 227:277-283.
8. Agirregoitia N., Casis L., Gil J., Ruiz F., Irazusta J. Ontogeny of prolyl endopeptidase and pyroglutamyl peptidase I in rat tissues. Regul Pept 2007, 139:52-58.
9. Tenorio-Laranga J., Venäläinen J.I., Männistö P.T., García-Hornsman J.A. Characterization of membrane-bound prolyl endopeptidase from brain. FEBS J 2008, 275:4415-4427.
10. Myöhänen T.T., Venäläinen J.I., García-Hornsman J.A., Piltonen M., Männistö P.T. Distribution of prolyl oligopeptidase in the mouse whole-body sections and peripheral tissues. Histochem Cell Biol 2008, 130:993-1003.
11. Myöhänen T.T., Venäläinen J.I., Tupala E., García-Hornsman J.A., Miettinen R., Männistö P.T. Distribution of immunoreactive prolyl oligopeptidase in human and rat brain. Neurochem Res 2007, 32:1365-1374.
12. Moreno-Baylach M.J., Felipo V., Männisto P.T., García-Hornsman J.A. Expression and traffic of cellular prolyl oligopeptidase are regulated during cerebellar granule cell differentiation, maturation, and aging. Neuroscience 2008, 156:580-585.
13. Antczak C., De Meester I., Bauvois B. Ectopeptidases in pathophysiology. Bioessays 2001, 23:251-260.
14. Carl-McGrath S., Lendeckel U., Ebert M., Röcken C. Ectopeptidases in tumour biology: a review. Histol Histopathol 2006, 26:1339-1353.
15. Vendeville S., Goossens F., Debreu-Fontaine M.A., Landry V., Davioud-Charvet E., Grellier P., Scharpe S., Sergheraert C. Comparison of the inhibition of human and Trypanosoma cruzi prolyl endopeptidases. Bioorg Med Chem 2002, 10:1719-1729.
16. Gass J., Bethune M.T., Siegel M., Spencer A., Khosla C. Combination enzyme therapy for gastric digestion of dietary gluten in patients with celiac sprue. Gastroenterology 2007, 133:472-480.
17. Männisto P.T., Venäläinen J., Jalkanen A., García-Horsman J.A. Prolyl oligopeptidase: a potential target for the treatment of cognitive disorders. Drug News Perspect 2007, 20:293-305.
18. Sedo A., Krepela E., Kasafírek E. Dipeptidil peptidase IV, prolyl endopeptidase and cathepsin B activities in primary human lung tumours and lung parenchyma. J Cancer Res Clin Oncol 1991, 117:249-253.
19. Liu J.L., Kusinski M., Ilic V., Bignon J., Hajem N., Komorowski J., Kuzdak K., Stepien H., Wdzieczak-Bakala J. Overexpression of the angiogenin tetrapeptide AcSDKP in human malignant tumors. Anticancer Res 2008, 28:2813-2818.
20. Yoshimoto T., Ogita K., Walter R., Koida M., Tsuru D. Post-proline cleaving enzyme. Synthesis of a new fluorogenic substrate and distribution of the endopeptidase in rat tissues and body fluids of man. Biochim Biophys Acta 1979, 569:184-192.
21. Bradford M.M. A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal Biochem 1976, 72:248-254.
22. Ino K., Shibata K., Kajiyama H., Kikkawa F., Mizutani S. Regulatory role of membrane-bound peptidases in the progression of gynecologic malignancies. Biol Chem 2004, 385:683-690.
23. Varona A., Blanco L., López J.I., Gil J., Agirregoitia E., Irazusta J., Larrinaga G. Altered levels of acid, basic, and neutral peptidase activity and expression in human clear cell renal cell carcinoma. Am J Physiol-Renal Physiol 2007, 292:780-788.
24. Larrinaga G., Lopez J.I., Casis L., Blanco L., Gil J., Agirregoitia E., Varona A. Cystinyl aminopeptidase activity is decreased in renal cell carcinomas. Regul Pept 2007, 144:56-61.
25. Blanco L., Larrinaga G., Pérez I., López J.I., Gil J., Agirregoitia E., Varona A. Acid, basic and neutral peptidases present different profiles in chromophobe renal cell carcinoma and in oncocytoma. Am J Physiol Ren Physiol 2008, 294:850-858.
26. Pérez I., Varona A., Blanco L., Gil J., Santaolalla F., Zabala A., Ibarguren A.M., Irazusta J., Larrinaga G. Increased APN/CD13 and acid aminopeptidase activities in head and neck squamous cell carcinoma. Head Neck 2009, 31:1335-1340.
27. Edosada C.Y., Quan C., Tran T., Pham V., Wiessman C., Fairbrother W., Wolf B.B. Peptide substrate profiling defines fibroblast activation protein as an endopeptidase of strict Gly(2)-Pro(1)-cleaving specificity. FEBS Lett 2006, 580:1581-1586.
28. Dohi O., Ohtani H., Hatori M., Sato E., Hosaka M., Nagura H., Itoi E., Kokubun S. Histogenesis-specific expression of fibroblast activation protein and dipeptidylpeptidase-IV in human bone and soft tissue tumours. Histopathol 2009, 55:432-440.
29. Ohtuski S., Homma K., Kurata S., Komano H., Natori S. A prolyl endopeptidase of Sarcophaga peregrina (flesh fly): its purification and suggestion for its participation in the differentiation of the imaginal discs. J Biochem (Tokyo) 1994, 115:449-453.
30. Ohtuski S., Homma K., Kurata S., Komano H., Natori S. Nuclear localization and involvement in DNA synthesis of Sarcophaga prolyl endopeptidase. J Biochem (Tokyo) 1997, 121:1176-1181.
31. Ishino T, Ohtuski S, Homma K, Natori S. cDNA cloning of mouse prolyl endopeptidase and its involvement in DNA synthesis by Swiss 3T3 cells. J Biochem (Tokyo).
32. Balogh A., Cadel S., Foulon T., et al. Aminopeptidase B: a processing enzyme secreted and associated with the plasma membrane of rat pheochromocytoma (PC12) cells. J Cell Sci 1998, 111:161-169.
33. Shrimpton C.N., Smith A.I., Lew R.A. Soluble metallopeptidases and neuroendocrine signaling. Endocr Rev 2002, 23:647-664.
34. Ahmed M.M., Arif M., Chikuma T., Kato T. Pentylenetetrazol-induced seizures affect the levels of prolyl oligopeptidase, thimet oligopeptidase and glial proteins in rat brain regions, and attenuation by MK-801 pretreatment. Neurochem Int 2005, 47:248-259.
35. Larrinaga G., Gil J., Meana J.J., Callado L.F., Ruiz F., Irazusta J. Aminopeptidase activity in the postmortem brain of human heroin addicts. Neurochem Int 2005, 46:213-219.
36. Re R.N., Cook J.L. The intracrine hypothesis: an update. Regul Pept 2005, 133:117-122.
37. Re R.N. Intracellular renin and nature of intracrine enzymes. Regul Pept 2003, 42:117-122.
38. Re R.N., Cook J.L. An intracrine view of angiogenesis. Bioessays 2006, 28:943-953.
39. Cierniewski C.S., Malinowski M., Bednarek R., Cierniewska-Cieslak A. Adhesive and proteolytic phenotype of migrating endothelial cells induced by thymosin beta-4. Ann NY Acad Sci 2007, 1112:123-139.
40. Lévesque M., Parent R., Parent A. Cellular and subcellular localization of neurokinin-3 receptors in primate globus pallidus. Eur J Neurosci 2006, 23:2760-2772.
41. Schulz I., Gerhartz B., Neubauer A., Holloschi A., Heiser U., Hafner M., Demuth H.U. Modulation of inositol 1, 4, 5-triphosphate concentration by prolyl endopeptidase inhibition. Eur J Biochem 2002, 269:5813-5820.
42. Schulz I., Zeitschel U., Rudolph T., Ruiz-Carrillo D., Rahfeld J.U., Gerhartz B., Bigl V., Demuth H.U., Rossner S. Subcellular localization suggests novel functions for prolyl endopeptidase in protein secretion. J Neurochem 2005, 94:970-979.
43. Tahara A., Tsukada J., Tomura Y., Momose K., Suzuki T., Yatsu T., Shibasaki M. Effects of YM218, a nonpeptide vasopressin V1A receptor-selective antagonist, on vasopressin-induced growth responses in human mesangial cells. Eur J Pharmacol 2006, 538:32-38.
44. Ager E.I., Neo J., Christophi C. The renin-angiotensin system and malignancy. Carcinogenesis 2008, 29:1675-1684.
45. Cavasin M.A., Rhaleb N.E., Yang X.P., Carretero O.A. Prolyl oligopeptidase is involved in release of the antifibrotic peptide Ac-SDKP. Hypertension 2004, 43:1140-1145.
46. Liu J.M., Bignon J., Ilic V., Briscoe C., Lallemand J.Y., Riches A., Wdzieczak-Bakala J. Evidence for an association of high levels of endogenous Acetyl-Ser-Asp-Lys-Pro, a potent mediator of angiogenesis, with acute myeloid leukemia development. Leuk Lymphoma 2006, 47:1915-1920.
47. Casarini D.E., Boim M.A., Stella R.C., Schor N. Endopeptidases (kininases) are able to hydrolyze kinins in tubular fluid along the rat nephron. Am J Physiol 1999, 277:64-74.
48. Naghettini A.V., Nogueira P.C., Juliano M., Bueno A.A., Casarini D.E., de Abreu Carvalhaes J.T. Tubular urinary enzymes in acute post-infectious glomerulonephritis. Pediatr Nephrol 2001, 16:719-722.
49. Göhring B., Holzhausen H.J., Meye A., Heynemann H., Rebmann U., Langner L., Riemann D. Endopeptidase 24.11/CD10 is down-regulated in renal cell cancer. Int J Mol Med 1998, 2:409-414.
50. Nanus D.M., Bogenrieder T., Papandreou C.N., Finstad C.L., Lee A., Vlamis V., Motzer R.J., Bander N.H., Albino A.P., Reuter V.E. Aminopeptidase A expression and enzymatic activity in primary human renal cancers. Int J Oncol 1998, 13:261-267.
51. López-Beltrán A., Carrasco J.C., Cheng L., Scarpelli M., Kirkali Z., Montironi R. 2009 update on the classification of renal epithelial tumors in adults. Int J Urol 2009, 16:432-443.
52. Jemal A., Siegel R., Ward E., Hao Y., Xu J., Thun M.J. Cancer statistics, 2009. CA Cancer J Clin 2009, 59:225-249.
53. Murakami H., Yokoyama A., Kondo K., Nakanishi S., Kohno N., Miyake M. Circulating aminopeptidase N/CD13 is an independent prognostic factor in patients with non-small cell lung cancer. Clin Cancer Res 2003, 11:8674-8679.
54. Ichinose Y., Genka K., Koike T., Kato H., Watanabe Y., Mori T., Lioka S., Sakuma A., Ohta M. Randomized double-blind placebo-controlled trial of bestatin in patients with resected stage I squamous-cell lung carcinoma. J Natl Cancer Inst 2003, 95:605-610.
55. Leslie A., Carey F.A., Pratt N.R., Steele R.J. The colorectal adenoma-carcinoma sequence. Br J Surg 2002, 89:845-860.
56. Hashida H., Takabayashi A., Kanai M., Adachi M., Kondo K., Kohno N., Yamaoka Y., Miyake M. Aminopeptidase N is involved in cell motility and angiogenesis: its clinical significance in human colon cancer. Gastroenterology 2002, 122:376-386.
57. Selvakumar P., Lakshmikuttyamma A., Kanthan R., Kanthan S.C., Dimmock J.R., Sharma R.K. High expression of methionine aminopeptidase 2 in human colorectal adenocarcinomas. Clin Cancer Res 2004, 10:2771-2775.
58. Talieri M., Mathioudaki K., Prezas P., Alexopoulou D.K., Diamandis E.P., Xynopouolos D., Ardavanis A., Arnogiannaki N., Scorilas A. Clinical significance of kallikrein-related peptidase 7 (KLK7) in colorectal cancer. Thromb Haemost 2009, 101:741-747.
59. Zucker S., Vacirca J. Role of matrix metalloproteinases (MMPs) in colorectal cancer. Cancer Metastasis Rev 2004, 23:101-107.
60. Petrovic N., Schacke W., Shapiro L.H. CD13/Aminopeptidase N in tumor growth and angiogenesis. Aminopeptidases in Biology and Disease 2004, 179-200. Kluwer Academic/Plenum Press, New York. N.M. Hooper, U. Lendeckel (Eds.).
61. Gaggar A., Jackson P.L., Noerager B.D., O'Reilly P.J., McQuaid D.B., Rowe S.M., Clancy J.P., Blalock J.E. A novel proteolytic cascade generates an extracellular matrix-derived chemoattractant in chronic neutrophilic inflammation. J Immunol 2008, 180:5662-5669.
62. Heslin M.J., Yan J., Johnson M.R., Weiss H., Diasio R.B., Urist M.M. Role of matrix metalloproteinases in colorectal carcinogenesis. Ann Surg 2001, 233:786-792.